Это видео недоступно.
Сожалеем об этом.
Canagliflozin (invokana) tablets - For diabetes & heart failure
HTML-код
- Опубликовано: 6 окт 2022
- Canagliflozin is a SGLT-2 inhibitor that induces weight loss. It is indicated for the treatment of type II diabetes mellitus and patients with risk of heart failure and renal disease. It reduces need of hospitalization and improves quality of life.
